1. Home
  2. ONTF vs DBVT Comparison

ONTF vs DBVT Comparison

Compare ONTF & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONTF
  • DBVT
  • Stock Information
  • Founded
  • ONTF 1998
  • DBVT 2002
  • Country
  • ONTF United States
  • DBVT France
  • Employees
  • ONTF N/A
  • DBVT N/A
  • Industry
  • ONTF Computer Software: Prepackaged Software
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ONTF Technology
  • DBVT Health Care
  • Exchange
  • ONTF Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • ONTF 231.9M
  • DBVT 239.9M
  • IPO Year
  • ONTF 2021
  • DBVT N/A
  • Fundamental
  • Price
  • ONTF $5.65
  • DBVT $8.11
  • Analyst Decision
  • ONTF Hold
  • DBVT Buy
  • Analyst Count
  • ONTF 4
  • DBVT 4
  • Target Price
  • ONTF $5.33
  • DBVT $14.81
  • AVG Volume (30 Days)
  • ONTF 156.2K
  • DBVT 102.2K
  • Earning Date
  • ONTF 05-07-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • ONTF N/A
  • DBVT N/A
  • EPS Growth
  • ONTF N/A
  • DBVT N/A
  • EPS
  • ONTF N/A
  • DBVT N/A
  • Revenue
  • ONTF $145,087,000.00
  • DBVT $3,497,000.00
  • Revenue This Year
  • ONTF N/A
  • DBVT $1,700.53
  • Revenue Next Year
  • ONTF N/A
  • DBVT $535.67
  • P/E Ratio
  • ONTF N/A
  • DBVT N/A
  • Revenue Growth
  • ONTF N/A
  • DBVT N/A
  • 52 Week Low
  • ONTF $4.35
  • DBVT $2.21
  • 52 Week High
  • ONTF $7.04
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • ONTF 64.48
  • DBVT 41.18
  • Support Level
  • ONTF $5.26
  • DBVT $8.33
  • Resistance Level
  • ONTF $5.73
  • DBVT $9.92
  • Average True Range (ATR)
  • ONTF 0.18
  • DBVT 0.86
  • MACD
  • ONTF 0.04
  • DBVT -0.34
  • Stochastic Oscillator
  • ONTF 85.63
  • DBVT 1.48

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: